ORBIMED ADVISORS LLC

Holdings History for Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX)

Symbol: EWTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 15,252,867 shares
Security Ownership %: 14%

Shares, Excluding Options vs Price

Value, Excluding Options

ORBIMED ADVISORS LLC ownership in Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share (EWTX)

12 May 2025 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15,252,867 shares of Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share (EWTX). This represents 14% ownership of the company. This is the first filing by ORBIMED ADVISORS LLC disclosing ownership of Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share (EWTX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ORBIMED ADVISORS LLC	14%		$234,894,152	15,252,867			$15.40	13D/A	09 May 2025	12 May 2025, 19:13

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	6%	0%	$251,709,940	15,518,492	0		$16.22	Q3 2025
30 Jun 2025	5.1%	+0.16%	$203,447,430	15,518,492	+496,771	+3.3%	$13.11	Q2 2025
31 Mar 2025	8%	0%	$330,477,862	15,021,721	0		$22.00	Q1 2025
31 Dec 2024	8.4%	0%	$401,079,951	15,021,721	0		$26.70	Q4 2024
30 Sep 2024	7.3%	0%	$400,929,733	15,021,721	0		$26.69	Q3 2024
30 Jun 2024	5.8%	0%	$270,541,195	15,021,721	0		$18.01	Q2 2024
31 Mar 2024	5.4%	+0.16%	$273,996,191	15,021,721	+454,545	+3.1%	$18.24	Q1 2024
31 Dec 2023	3.2%	0%	$159,364,905	14,567,176	0		$10.94	Q4 2023
30 Sep 2023	1.9%	0%	$83,469,918	14,567,176	0		$5.73	Q3 2023
30 Jun 2023	2.2%	0%	$112,895,614	14,567,176	0		$7.75	Q2 2023
31 Mar 2023	1.9%	0%	$97,163,064	14,567,176	0		$6.67	Q1 2023
31 Dec 2022	2.7%	0%	$130,230,553	14,567,176	0		$8.94	Q4 2022
30 Sep 2022	2.9%	+0.1%	$143,341,000	14,567,176	+484,496	+3.4%	$9.84	Q3 2022
30 Jun 2022	2.2%	+0.02%	$112,098,000	14,082,680	+138,000	+0.99%	$7.96	Q2 2022
31 Mar 2022	2.2%	0%	$135,263,000	13,944,680	0		$9.70	Q1 2022
31 Dec 2021	2.8%	0%	$213,075,000	13,944,680	0		$15.28	Q4 2021
30 Sep 2021	2.6%	0%	$231,482,000	13,944,680	0		$16.60	Q3 2021
30 Jun 2021	3.1%	0%	$297,440,000	13,944,680	0		$21.33	Q2 2021
31 Mar 2021	4.5%	+4.5%	$453,202,000	13,944,680	+13,944,680	NEW	$32.50	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.